Today on Outsourcing-Pharma.com   J&J Belgium suffers strike over job cuts Russia's clinical biz showing signs of recovery after biologics ban Caliper launches combo drug testing services APIcross goes solo in drug delivery NeoMPS gets acquired

Related Industry News   Pipeline match following Celgene's $2.9bn acquisition of Pharmion Stem cell breakthrough avoids the embryo controversy Icahn invests in Genzyme, prompts takeover rumours Ventana reluctantly opens up to Roche in a bid to boost offer

Breaking News on Outsourcing Pharma
Daily  Monday 19 November 2007		Forward to a colleague

	Sponsored Link Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here Access Full Stories J&J Belgium suffers strike over job cuts Workers at Johnson & Johnson's (J&J's) Belgium subsidiary went on strike today in protest at the compensation being offered to those at the firm falling foul of the dreaded pharma axe... Read Russia's clinical biz showing signs of recovery after biologics ban Russia's clinical trials industry appears to be making a gradual recovery from a setback earlier this year when the government imposed an unexpected ban on biologic exports... Read Caliper launches combo drug testing services Caliper Life Sciences has launched new testing services that will help researchers weed out unsuitable combination drug therapies in the preclinic... Read APIcross goes solo in drug delivery Contract pharmaceutical development company Azopharma has carved out its drug delivery segment into a new company, APIcross Drug Delivery Technologies... Read NeoMPS gets acquired PolyPeptide Laboratories Group is to acquire the peptide manufacturing group NeoMPS... Read
	All News Headlines for: November | October | September
	Case Study Baxter's contract services case study Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization... Click Here
	Related Industry News Pipeline match following Celgene's $2.9bn acquisition of Pharmion Celgene has agreed to pay $2.9bn for Pharmion in the hope of becoming a 'global leader in the haematology and oncology field', but do the company's pipelines match up well together?... Read Stem cell breakthrough avoids the embryo controversy US researchers have developed a way of creating primate embryonic stem cells that avoids the need to use fertilised embryos, potentially leading to more ethical ways of curing degenerative diseases... Read Icahn invests in Genzyme, prompts takeover rumours The man often credited with causing Biogen Idec to be put up for sale, billionaire corporate raider Carl Icahn, has invested in Genzyme and promptly started industry tongues wagging about a takeover... Read Ventana reluctantly opens up to Roche in a bid to boost offer In the latest twist in Roche's fight to acquire diagnostics expert Ventana, the companies have signed a confidentiality agreement that will enable the pharma giant access to Ventana's books... Read Weekly Comment FDA failure on foreign inspections frightening A US government audit has confirmed the Food and Drug Administration's (FDA's) continual lack of inspection of foreign drug manufacturing plants. Read Sponsored Linnk Oncological API Specialist ScinoPharm, specialized in manufacturing cGMP grade oncological APIs, offers fully integrated services to develop and manufacture final APIs capabilities including process research and development, analytical development and regulatory submission... Click Here Previous Headlines Celesio sees profits drag Celesio fingerpointed two 'extraordinary items' in its dominant Wholesale division for the drag on company profits during the third quarter... Read Extra breathing space for epinephrine MDI ban The US Food and Drug Administration (FDA) has given stakeholders an extra month to get their views in on scrapping epinephrine inhalers containing CFCs... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving GATC Biotech, NextGen Sciences and Genedata... Read AMRI continues growth Albany Molecular Research Inc (AMRI) recently turned in Q3 results, posting figures buoyed by continued demand for its pharmaceutical development services... Read PRA's profits will soon be private PRA International continues to see its profits ebb away but will soon face less financial scrutiny as it nears a handover of ownership into private hands. ... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com